Providence Capital Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.8M Buy
65,961
+14,977
+29% +$1.73M 1.18% 28
2026
Q1
$6.09M Buy
50,984
+553
+1% +$72.5K 0.99% 46
2025
Q4
$6.87M Buy
50,431
+250
+0.5% +$36K 1.16% 29
2025
Q3
$7.4M Buy
50,181
+1,164
+2% +$161K 1.28% 26
2025
Q2
$6.34M Buy
49,017
+862
+2% +$104K 1.16% 35
2025
Q1
$5.75M Buy
48,155
+914
+2% +$113K 1.2% 33
2024
Q4
$5.48M Buy
47,241
+332
+0.7% +$42K 1.11% 43
2024
Q3
$6.33M Buy
46,909
+531
+1% +$71K 1.26% 29
2024
Q2
$6.29M Buy
46,378
+356
+0.8% +$48.4K 1.37% 21
2024
Q1
$5.95M Buy
46,022
+894
+2% +$108K 1.3% 30
2023
Q4
$5.16M Sell
45,128
-199
-0.4% -$19.9K 1.24% 34
2023
Q3
$4.13M Sell
45,327
-361
-0.8% -$37.2K 1.08% 46
2023
Q2
$5.15M Sell
45,688
-341
-0.7% -$36.1K 1.31% 31
2023
Q1
$4.82M Buy
46,029
+812
+2% +$84.8K 1.27% 27
2022
Q4
$5M Buy
45,217
+525
+1% +$55K 1.35% 24
2022
Q3
$3.9M Buy
44,692
+5,681
+15% +$516K 1.17% 34
2022
Q2
$3.05M Sell
39,011
-2,301
-6% -$190K 0.89% 51
2022
Q1
$3.52M Buy
41,312
+15,416
+60% +$1.48M 0.86% 53
2021
Q4
$3.1M Buy
25,896
+683
+3% +$84.8K 0.86% 52
2021
Q3
$3.12M Sell
25,213
-17,040
-40% -$2.19M 0.97% 44
2021
Q2
$5.07M Buy
42,253
+1,019
+2% +$116K 1.64% 16
2021
Q1
$4.34M Buy
41,234
+1,676
+4% +$170K 1.58% 21
2020
Q4
$4.03M Buy
39,558
+2,970
+8% +$279K 1.65% 18
2020
Q3
$3.08M Sell
36,588
-538
-1% -$41.9K 1.62% 20
2020
Q2
$2.41M Sell
37,126
-487
-1% -$32.1K 1.37% 36
2020
Q1
$2.45M Buy
37,613
+4,009
+12% +$316K 1.48% 22
2019
Q4
$2.65M Buy
33,604
+312
+0.9% +$24.3K 1.42% 30
2019
Q3
$2.65M Buy
33,292
+1,057
+3% +$83K 1.56% 24
2019
Q2
$2.7M Buy
32,235
+828
+3% +$66K 1.6% 15
2019
Q1
$2.48M Buy
31,407
+651
+2% +$47.5K 1.56% 21
2018
Q4
$2.05M Buy
30,756
+1,264
+4% +$87.4K 1.41% 22
2018
Q3
$2.36M Buy
29,492
+991
+3% +$74K 1.54% 16
2018
Q2
$1.92M Buy
28,501
+1,655
+6% +$120K 1.35% 25
2018
Q1
$2.06M Buy
26,846
+1,306
+5% +$96.6K 1.55% 13
2017
Q4
$1.74M Buy
+25,540
New +$1.7M 1.35% 27

Other funds holding XYL

Providence Capital Advisors's XYL Position: Q2 2026 in Review

Providence Capital Advisors increased its Xylem (XYL) stake by 29% in Q2 2026, buying an estimated $1.73M and bringing the position to 65,961 shares worth $7.8M. The position accounts for 1.18% of the portfolio, ranked #28.

Providence Capital Advisors first reported a position in XYL in Q4 2017 and has held it in 35 quarters since. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Providence Capital Advisors held 65,961 shares of Xylem worth $7.8M as of Q2 2026.
  • Providence Capital Advisors bought 14,977 Xylem shares in Q2 2026, an estimated $1.73M.
  • Xylem made up 1.18% of Providence Capital Advisors's portfolio in Q2 2026, its #28 holding.
  • Providence Capital Advisors first reported a position in Xylem in Q4 2017 and has held it in 35 quarters since.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Providence Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.